| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 927.89B | 916.62B | 678.64B | 664.50B | 1.06T |
| Gross Profit | 919.19B | 908.77B | 678.64B | 664.50B | 1.06T |
| EBITDA | 221.61B | 207.86B | 163.69B | 183.38B | 184.18B |
| Net Income | 131.29B | 126.61B | 85.67B | 111.01B | 101.62B |
Balance Sheet | |||||
| Total Assets | 13.90T | 12.96T | 11.58T | 11.01T | 10.14T |
| Cash, Cash Equivalents and Short-Term Investments | 269.72B | 950.37B | 797.92B | 746.52B | 630.51B |
| Total Debt | 2.61T | 1.40T | 1.49T | 1.48T | 1.59T |
| Total Liabilities | 12.49T | 11.65T | 10.35T | 9.82T | 9.06T |
| Stockholders Equity | 1.00T | 928.60B | 899.01B | 869.19B | 812.40B |
Cash Flow | |||||
| Free Cash Flow | 655.67B | 375.80B | 352.59B | 467.90B | 77.93B |
| Operating Cash Flow | 663.81B | 382.47B | 360.40B | 476.78B | 90.12B |
| Investing Cash Flow | -689.73B | -416.25B | -104.00B | -215.76B | 27.93B |
| Financing Cash Flow | 199.24B | 30.95B | -222.06B | -230.87B | -136.41B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | HK$1.08T | 4.51 | 31.07% | 3.42% | 17.69% | 126.41% | |
72 Outperform | HK$205.64B | 4.31 | 38.67% | 5.24% | 39.01% | 38.60% | |
71 Outperform | HK$389.14B | 9.89 | 18.91% | 3.28% | 10.54% | 27.66% | |
68 Neutral | HK$339.29B | -37.16 | 15.71% | 3.05% | 9.46% | 9.49% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | HK$1.20T | 139.89 | 13.93% | 4.25% | >-0.01% | 6.63% | |
65 Neutral | HK$892.68B | 17.34 | 15.16% | 2.16% | 9.97% | -4.43% |